• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年房颤患者的死亡原因及相关因素——长期回顾性研究

Cause of Death and Associated Factors in Elderly Patients With Atrial Fibrillation - Long-Term Retrospective Study.

作者信息

Oba Kageyuki, Shinjo Tetsuji, Tamashiro Masahiro, Matsuoka Mitsuteru, Arasaki Osamu, Arima Hisatomi, Inoue Taku

机构信息

Cardiovascular Medicine, Tomishiro Central Hospital Okinawa Japan.

Cardiovascular Medicine, Nambu Hospital Okinawa Japan.

出版信息

Circ Rep. 2020 Aug 29;2(9):490-498. doi: 10.1253/circrep.CR-20-0079.

DOI:10.1253/circrep.CR-20-0079
PMID:33693274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7819663/
Abstract

Oral anticoagulant (OAC) therapy reduces the risk of stroke in patients with atrial fibrillation (AF). This study elucidated the causes of death and related factors in elderly Japanese AF patients. Over a median (interquartile range [IQR]) follow-up period of 46 (20-76) months, there were 171 all-cause deaths (28% cardiovascular, 46% non-cardiovascular, and 26% unknown causes) among 389 AF patients (median [IQR] age 80 [74-85] years; CHADDS-VASc score 5 [4-6]). Cox regression analysis indicated that diabetes was associated with an increase in all-cause death (hazard ratio [HR] 1.48; 95% confidence interval [CI] 1.02-2.13), whereas hypercholesterolemia (HR 0.53; 95% CI 0.35-0.79), pre-existing heart failure (HR 0.67; 95% CI 0.48-0.95), and OAC use (HR 0.62; 95% CI 0.44-0.88) were associated with reductions in all-cause death. Pre-existing heart failure was associated with both cardiovascular (HR 3.03; 95% CI 1.33-8.20) and non-cardiovascular (HR 0.44; 95% CI 0.30-0.65) deaths, in opposite directions. OAC use was associated with a reduction in cardiovascular death (HR 0.34, 95% CI 0.17-0.69). The predominance of non-cardiovascular death and death-related factors were equivalent regardless of when observations started (before 2009 or in 2009 and later). The predominant cause of death in elderly Japanese AF patients was non-cardiovascular. Distinct clinical factors were associated with cardiovascular and non-cardiovascular death.

摘要

口服抗凝剂(OAC)治疗可降低心房颤动(AF)患者的中风风险。本研究阐明了日本老年AF患者的死亡原因及相关因素。在中位(四分位间距[IQR])随访期46(20 - 76)个月内,389例AF患者(中位[IQR]年龄80[74 - 85]岁;CHADDS-VASc评分5[4 - 6])中有171例全因死亡(28%为心血管原因,46%为非心血管原因,26%原因不明)。Cox回归分析表明,糖尿病与全因死亡增加相关(风险比[HR]1.48;95%置信区间[CI]1.02 - 2.13),而高胆固醇血症(HR 0.53;95% CI 0.35 - 0.79)、既往存在心力衰竭(HR 0.67;95% CI 0.48 - 0.95)和使用OAC(HR 0.62;95% CI 0.44 - 0.88)与全因死亡减少相关。既往存在心力衰竭与心血管死亡(HR 3.03;95% CI 1.33 - 8.20)和非心血管死亡(HR 0.44;95% CI 0.30 - 0.65)均相关,方向相反。使用OAC与心血管死亡减少相关(HR 0.34,95% CI 0.17 - 0.69)。无论观察从何时开始(2009年之前或2009年及以后),非心血管死亡的优势及死亡相关因素均相当。日本老年AF患者的主要死亡原因是非心血管性的。不同的临床因素与心血管死亡和非心血管死亡相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621d/7819663/7f4795b63697/circrep-2-490-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621d/7819663/242b9e222448/circrep-2-490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621d/7819663/496220f939b2/circrep-2-490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621d/7819663/7f4795b63697/circrep-2-490-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621d/7819663/242b9e222448/circrep-2-490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621d/7819663/496220f939b2/circrep-2-490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621d/7819663/7f4795b63697/circrep-2-490-g003.jpg

相似文献

1
Cause of Death and Associated Factors in Elderly Patients With Atrial Fibrillation - Long-Term Retrospective Study.老年房颤患者的死亡原因及相关因素——长期回顾性研究
Circ Rep. 2020 Aug 29;2(9):490-498. doi: 10.1253/circrep.CR-20-0079.
2
Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke.非永久性心房颤动与口服抗凝治疗与首次缺血性卒中后10年的生存率相关。
Int J Cardiol. 2017 Apr 1;232:134-139. doi: 10.1016/j.ijcard.2017.01.040. Epub 2017 Jan 5.
3
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.新发心房颤动与急性冠状动脉综合征病史的结局:来自 GARFIELD-AF 的见解。
Am J Med. 2019 Dec;132(12):1431-1440.e7. doi: 10.1016/j.amjmed.2019.06.008. Epub 2019 Jul 12.
4
All-Cause Death and Major Adverse Events in Atrial Fibrillation with Frailty: Observations from the Korea National Health Insurance Service Data.虚弱型心房颤动患者的全因死亡和主要不良事件:来自韩国国民健康保险服务数据的观察结果
Rev Cardiovasc Med. 2024 Jan 30;25(2):52. doi: 10.31083/j.rcm2502052. eCollection 2024 Feb.
5
Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry.日本心房颤动患者的死亡原因:伏见心房颤动注册研究。
Eur Heart J Qual Care Clin Outcomes. 2019 Jan 1;5(1):35-42. doi: 10.1093/ehjqcco/qcy033.
6
Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.抗栓治疗对伴有慢性肾脏病的心房颤动患者的净临床获益:一项全国性观察性队列研究。
J Am Coll Cardiol. 2014 Dec 16;64(23):2471-82. doi: 10.1016/j.jacc.2014.09.051.
7
Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients.停止口服抗凝治疗是房颤患者中风和死亡的一个重要危险因素。
Thromb Haemost. 2017 Jun 27;117(7):1448-1454. doi: 10.1160/TH16-12-0961. Epub 2017 Mar 23.
8
Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study.创伤后恢复口服抗凝治疗与心房颤动患者的卒中与出血风险:一项全国性队列研究。
Eur Heart J. 2018 May 14;39(19):1698-1705a. doi: 10.1093/eurheartj/ehx598.
9
Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.HAS-BLED 出血风险评分与抗凝治疗的心房颤动患者的大出血、心血管事件和死亡率的关系。
Circ Arrhythm Electrophysiol. 2012 Apr;5(2):312-8. doi: 10.1161/CIRCEP.111.967000. Epub 2012 Feb 7.
10
Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.心房颤动患者的死亡原因和影响因素。
Am J Med. 2016 Dec;129(12):1278-1287. doi: 10.1016/j.amjmed.2016.06.045. Epub 2016 Jul 28.

引用本文的文献

1
Impact of preexisting diabetes mellitus on cardiovascular and all-cause mortality in patients with atrial fibrillation: A meta-analysis.预先存在的糖尿病对心房颤动患者心血管和全因死亡率的影响:一项荟萃分析。
Front Endocrinol (Lausanne). 2022 Aug 1;13:921159. doi: 10.3389/fendo.2022.921159. eCollection 2022.
2
Contemporary survival and anticoagulation of patients with atrial fibrillation: A community based cohort study in China.中国心房颤动患者的当代生存率及抗凝治疗:一项基于社区的队列研究
Front Cardiovasc Med. 2022 Jul 27;9:911393. doi: 10.3389/fcvm.2022.911393. eCollection 2022.

本文引用的文献

1
Cardiovascular risk profile and frailty in Japanese outpatients: the Nambu Cohort Study.日本门诊患者的心血管风险状况与衰弱:难波队列研究
Hypertens Res. 2020 Aug;43(8):817-823. doi: 10.1038/s41440-020-0427-z. Epub 2020 Mar 17.
2
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).日本高血压学会高血压管理指南(JSH 2019)。
Hypertens Res. 2019 Sep;42(9):1235-1481. doi: 10.1038/s41440-019-0284-9.
3
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.
日本动脉粥样硬化协会(JAS)2017年动脉粥样硬化性心血管疾病预防指南。
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22.
4
Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry.日本心房颤动患者的死亡原因:伏见心房颤动注册研究。
Eur Heart J Qual Care Clin Outcomes. 2019 Jan 1;5(1):35-42. doi: 10.1093/ehjqcco/qcy033.
5
What is the Impact of Frailty on Prescription of Anticoagulation in Elderly Patients with Atrial Fibrillation? A Systematic Review and Meta-Analysis.衰弱对老年房颤患者抗凝治疗处方有何影响?一项系统评价和荟萃分析。
J Atr Fibrillation. 2018 Apr 30;10(6):1870. doi: 10.4022/jafib.1870. eCollection 2018 Apr.
6
Japanese Clinical Practice Guideline for Diabetes 2016.《2016年日本糖尿病临床实践指南》
J Diabetes Investig. 2018 Mar 26;9(3):657-97. doi: 10.1111/jdi.12810.
7
Trajectory of Total Cholesterol in the Last Years of Life Over Age 80 Years: Cohort Study of 99,758 Participants.80 岁以上人群生命终末期总胆固醇的变化轨迹:99758 名参与者的队列研究。
J Gerontol A Biol Sci Med Sci. 2018 Jul 9;73(8):1083-1089. doi: 10.1093/gerona/glx184.
8
Systolic Blood Pressure Trajectory, Frailty, and All-Cause Mortality >80 Years of Age: Cohort Study Using Electronic Health Records.收缩压轨迹、衰弱与80岁以上人群的全因死亡率:使用电子健康记录的队列研究
Circulation. 2017 Jun 13;135(24):2357-2368. doi: 10.1161/CIRCULATIONAHA.116.026687. Epub 2017 Apr 21.
9
Causes of Death in Anticoagulated Patients With Atrial Fibrillation.抗凝治疗的心房颤动患者的死亡原因。
J Am Coll Cardiol. 2016 Dec 13;68(23):2508-2521. doi: 10.1016/j.jacc.2016.09.944.
10
Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.心房颤动患者的死亡原因和影响因素。
Am J Med. 2016 Dec;129(12):1278-1287. doi: 10.1016/j.amjmed.2016.06.045. Epub 2016 Jul 28.